1. Home/
  2. Compounds/
  3. selumetinib:PLX-4032 (8:1 mol/mol)

selumetinib:PLX-4032 (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:PLX-4032 (8:1 mol/mol)
PharmacoGx selumetinib:PLX-4032 (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:PLX-4032 (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA E2F2 CTRPv2 pan-cancer AAC -0.22 2e-07
mRNA SAMD1 CTRPv2 pan-cancer AAC -0.2 2e-07
mRNA KIF1A CTRPv2 pan-cancer AAC -0.2 2e-07
mRNA SP4 CTRPv2 pan-cancer AAC -0.19 2e-07
mRNA RAB11FIP3 CTRPv2 pan-cancer AAC -0.19 2e-07
mRNA LGALS3 CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA SCN8A CTRPv2 pan-cancer AAC -0.2 3e-07
mRNA SMAD4 CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA UPF3B CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA OSBPL5 CTRPv2 pan-cancer AAC 0.18 3e-07
Download CSV